Cargando…
297. Lactobacillus: Friend or Foe
BACKGROUND: Lactobacillus are low virulence commensal organisms which are commonly found in the human oral cavity, gastrointestinal and genitourinary tracts. Although Lactobacillus bacteremia (LB) is rare, evidence aggregating from case reports has implicated LB in several medical conditions. As suc...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777954/ http://dx.doi.org/10.1093/ofid/ofaa439.340 |
_version_ | 1783631024233644032 |
---|---|
author | Nwanyanwu, Chiemeziem Shobayo, Anuoluwapo Ghitan, Monica Chapnick, Edward Kuhn-Basti, Margaret Lin, Yu Shia Simon, Samuel Li, Rosanna |
author_facet | Nwanyanwu, Chiemeziem Shobayo, Anuoluwapo Ghitan, Monica Chapnick, Edward Kuhn-Basti, Margaret Lin, Yu Shia Simon, Samuel Li, Rosanna |
author_sort | Nwanyanwu, Chiemeziem |
collection | PubMed |
description | BACKGROUND: Lactobacillus are low virulence commensal organisms which are commonly found in the human oral cavity, gastrointestinal and genitourinary tracts. Although Lactobacillus bacteremia (LB) is rare, evidence aggregating from case reports has implicated LB in several medical conditions. As such, there is reason to suggest that the presence of these organisms in blood cultures may not be due to spurious contamination, but rather, indicative of clinically meaningful events capable of inducing serious illnesses. The purpose of this study is to characterize the risk factors, clinical significance and outcomes of patients with LB. METHODS: We retrospectively reviewed the medical records of patients presenting to a large urban teaching hospital between January 1, 2017 and December 31, 2018, who were found to have LB. Identified individuals were grouped into two mutually exclusive case categories: true LB cases or non-true cases (i.e., contamination). Individuals with ≥1 positive blood and were started on appropriate antibiotics were considered true cases. Those with positive cultures not started on appropriate antibiotics were considered contaminants. RESULTS: A total of 14 patients were identified during our study period, with majority considered true LB cases [71.4%; n = 10]. These 14 individuals were mostly males [64.2%; n = 9] and reported no use of Lactobacilli probiotics [78.6%; n = 11] or antacids [57.1%; n = 8]. On average, true LB cases were older (mean [SD]): 80.1 [±10.9]vs. 54.0 [±19.1] years) and required longer hospitalization (38.5 [(±27.6] vs. 8.0 [(±6.2] days) compared to non-LB cases, respectively. Among the 10 true LB cases, the suspected source of infection included gastrointestinal system [50%; n = 5], infective endocarditis [10%; n = 1], genitourinary system [10%; n = 1]; and could not be determined in 3 [30%] cases. Concurrent infection with candida and gastrointestinal microbes were noted in four (40%) of the true LB cases, respectively. Overall, five deaths were observed, with 4 [80%] occurring in true LB cases and one in a non-LB case. CONCLUSION: LB should not be dismissed as contaminants particularly in at-risk patients for LB, such as the elderly or immunocompromised individuals. DISCLOSURES: All Authors: No reported disclosures |
format | Online Article Text |
id | pubmed-7777954 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-77779542021-01-07 297. Lactobacillus: Friend or Foe Nwanyanwu, Chiemeziem Shobayo, Anuoluwapo Ghitan, Monica Chapnick, Edward Kuhn-Basti, Margaret Lin, Yu Shia Simon, Samuel Li, Rosanna Open Forum Infect Dis Poster Abstracts BACKGROUND: Lactobacillus are low virulence commensal organisms which are commonly found in the human oral cavity, gastrointestinal and genitourinary tracts. Although Lactobacillus bacteremia (LB) is rare, evidence aggregating from case reports has implicated LB in several medical conditions. As such, there is reason to suggest that the presence of these organisms in blood cultures may not be due to spurious contamination, but rather, indicative of clinically meaningful events capable of inducing serious illnesses. The purpose of this study is to characterize the risk factors, clinical significance and outcomes of patients with LB. METHODS: We retrospectively reviewed the medical records of patients presenting to a large urban teaching hospital between January 1, 2017 and December 31, 2018, who were found to have LB. Identified individuals were grouped into two mutually exclusive case categories: true LB cases or non-true cases (i.e., contamination). Individuals with ≥1 positive blood and were started on appropriate antibiotics were considered true cases. Those with positive cultures not started on appropriate antibiotics were considered contaminants. RESULTS: A total of 14 patients were identified during our study period, with majority considered true LB cases [71.4%; n = 10]. These 14 individuals were mostly males [64.2%; n = 9] and reported no use of Lactobacilli probiotics [78.6%; n = 11] or antacids [57.1%; n = 8]. On average, true LB cases were older (mean [SD]): 80.1 [±10.9]vs. 54.0 [±19.1] years) and required longer hospitalization (38.5 [(±27.6] vs. 8.0 [(±6.2] days) compared to non-LB cases, respectively. Among the 10 true LB cases, the suspected source of infection included gastrointestinal system [50%; n = 5], infective endocarditis [10%; n = 1], genitourinary system [10%; n = 1]; and could not be determined in 3 [30%] cases. Concurrent infection with candida and gastrointestinal microbes were noted in four (40%) of the true LB cases, respectively. Overall, five deaths were observed, with 4 [80%] occurring in true LB cases and one in a non-LB case. CONCLUSION: LB should not be dismissed as contaminants particularly in at-risk patients for LB, such as the elderly or immunocompromised individuals. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2020-12-31 /pmc/articles/PMC7777954/ http://dx.doi.org/10.1093/ofid/ofaa439.340 Text en © The Author 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Poster Abstracts Nwanyanwu, Chiemeziem Shobayo, Anuoluwapo Ghitan, Monica Chapnick, Edward Kuhn-Basti, Margaret Lin, Yu Shia Simon, Samuel Li, Rosanna 297. Lactobacillus: Friend or Foe |
title | 297. Lactobacillus: Friend or Foe |
title_full | 297. Lactobacillus: Friend or Foe |
title_fullStr | 297. Lactobacillus: Friend or Foe |
title_full_unstemmed | 297. Lactobacillus: Friend or Foe |
title_short | 297. Lactobacillus: Friend or Foe |
title_sort | 297. lactobacillus: friend or foe |
topic | Poster Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777954/ http://dx.doi.org/10.1093/ofid/ofaa439.340 |
work_keys_str_mv | AT nwanyanwuchiemeziem 297lactobacillusfriendorfoe AT shobayoanuoluwapo 297lactobacillusfriendorfoe AT ghitanmonica 297lactobacillusfriendorfoe AT chapnickedward 297lactobacillusfriendorfoe AT kuhnbastimargaret 297lactobacillusfriendorfoe AT linyushia 297lactobacillusfriendorfoe AT simonsamuel 297lactobacillusfriendorfoe AT lirosanna 297lactobacillusfriendorfoe |